Hantz Financial Services, Inc. Astrazeneca PLC Transaction History
Hantz Financial Services, Inc.
- $5.63 Billion
- Q3 2024
A detailed history of Hantz Financial Services, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 44,514 shares of AZN stock, worth $2.93 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
44,514
Previous 44,112
0.91%
Holding current value
$2.93 Million
Previous $3.44 Million
0.81%
% of portfolio
0.06%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.14 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.77 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.45 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.43 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.26 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $204B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...